Tag: Vaping cessation

According to a 2025 study in the journal *JAMA*, the smoking cessation drug varenicline has shown significant effectiveness in helping young adults quit nicotine vaping. While there is no single FDA-approved medication specifically for e-cigarettes, doctors often prescribe medications and Nicotine Replacement Therapy to manage cravings and withdrawal symptoms.

With an estimated 1.6 million middle and high school students in the United States reporting e-cigarette use in 2024, the need for effective quitting methods is urgent. While there is no single new FDA-approved medication specifically for this purpose, research is advancing rapidly, and several promising drug candidates and repurposed therapies are emerging in the quest to find a new drug to stop vaping.

Over two-thirds of American smokers express a desire to quit, yet many face significant challenges that lead to relapse. For those struggling to overcome nicotine addiction, a promising new option is on the horizon: Cytisinicline, the new medication for quitting smoking that is currently under review by the U.S. Food and Drug Administration (FDA). This plant-based alkaloid has shown strong clinical trial results and may become the first new prescription smoking cessation treatment approved in nearly 20 years.